Strategic Partnership for Drug Target Discovery
BullFrog AI and the Lieber Institute for Brain Development (LIBD) have partnered to enable the discovery and development of precision treatments for CNS disorders. LIBD is a non-profit research institute that maintains the largest collection of postmortem brains for the study of neuropsychiatric disorders in the world. Paired with BullFrog AI’s state-of-the-art causal AI and machine learning, this program has identified novel subgroups within neuropsychiatric disorders, including major depression, schizophrenia, and bipolar disorder.
Solutions for Challenges in CNS Target Discovery
Unique Best-in-Class CNS Dataset
The BullFrog AI Discovery Process
